Ventyx Biosciences Total Current Liabilities

Ventyx Biosciences's total current liabilities stands at $11M as of September 2025. That compares with $12M in the prior-year period — down 8.5% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Ventyx Biosciences reported $11M in total current liabilities versus $12M a year earlier — a 8.5% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $12M in the prior-year period — down 8.5% year over year. Sustained growth in total current liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Ventyx Biosciences's total current liabilities evolved across reporting periods, while the comparison chart places VTYX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.